GlassScriptPhysician profile
Tyler Calkins
NPI 1316501323
$11,210.46
in general payments reported to CMS, 2019-2025
5 companies · $8,277 in 2025
The $8,277 reported for 2025 was more than what 75% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,934 · 2025: $8,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $3,430 · Food and Beverage: $2,643 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $3,430.17 |
| Food and Beverage | $2,643.28 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,137.95 | 2024-2025 | Real Intelligence |
| Medical Device Business Services, INC. | $2,882.53 | 2025 | Actis, Attune, Dermabond |
| Stryker Corporation | $2,592.62 | 2024-2025 | Mako, Triathlon, Insignia |
| Depuy Synthes Sales INC. | $438.63 | 2024-2025 | Attune, Actis, Inhance |
| Orthalign INC | $158.73 | 2024 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Calkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.